Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
Innotox or Botox: Same Toxin, Different Format — What Actually Differs
Written by FillersFairy Editorial · Reviewed by FillersFairy Clinical Team · Last updated: [PUBLISH_DATE]
Quick Answer
Innotox and Botox both contain botulinum toxin type A with a 1:1 unit conversion — 20 units of Innotox produces the same clinical effect as 20 units of Botox. The real difference is format: Innotox is a pre-mixed liquid (4U/0.1 mL, no reconstitution, onset 24–48 hours). Botox is a vacuum-dried formulation (reconstitute with saline, onset 3–5 days). Both last 4–6 months. Both use the same injection techniques and the same anatomical points. The choice is operational — liquid convenience vs established brand ecosystem.
The Comparison That Matters
| Feature | Innotox (Medytox) | Botox (Allergan) |
|---|---|---|
| Active ingredient | Botulinum toxin type A | Botulinum toxin type A (onabotulinumtoxinA) |
| Unit conversion | 1:1 — same units, same effect | |
| Format | Pre-mixed liquid | Vacuum-dried formulation |
| Reconstitution | Not required | Required (add saline) |
| Concentration | Fixed: 4U per 0.1 mL | Variable (depends on dilution) |
| Onset | 24–48 hours | 3–5 days |
| Peak effect | Day 7–14 | Day 7–14 |
| Duration | 4–6 months | 4–6 months |
| Vial sizes | 50U / 100U | 50U / 100U / 200U |
| Stabiliser | Albumin-free | Human serum albumin 500 mcg |
| Storage | 2–8°C, 36 months | 2–8°C (or ≤25°C pre-reconstitution) |
| Regulatory | KFDA | FDA + global |
| Manufacturer | Medytox (South Korea) | Allergan / AbbVie (USA) |
Potency: The 1:1 Conversion Fact
The most important clinical fact: Innotox and Botox use identical units at a 1:1 ratio. A glabellar treatment requiring 20U of Botox requires 20U of Innotox. No conversion factor. No dose adjustment. Same injection points, same depth, same technique.
This means switching a patient between Botox and Innotox requires zero protocol change. The only difference is what happens before the needle enters skin — reconstitution vs ready-to-inject.
Format: Why It Matters More Than You Think
Consistency. Every time a practitioner reconstitutes Botox, three variables come into play: exact saline volume, mixing technique and timing. Most practitioners do this perfectly — but the potential for variation exists. Innotox eliminates all three variables. The concentration is always 4U/0.1 mL, every vial, every time.
Speed. Reconstitution adds 5–10 minutes per vial. For a clinic treating 15+ BTX-A patients per day, that compounds into 1.5–2.5 hours of daily preparation time. Innotox converts that time into patient-facing treatment time.
Onset. Innotox’s liquid format delivers pre-dissolved toxin that reaches neuromuscular junctions faster — patients typically see visible onset within 24–48 hours versus 3–5 days for Botox. By Day 14, both achieve the same peak effect.
Cost: The Real Calculation
Per-unit wholesale cost favours Innotox at Korean wholesale pricing. But the cost comparison isn’t just about unit price:
Product cost per treatment: At wholesale, Innotox costs less per unit than Botox’s retail/distributor pricing in most markets. The exact difference varies by volume and supplier relationship.
Time cost per treatment: Eliminating reconstitution saves practitioner time. At typical hourly rates, this operational saving offsets any per-unit price difference.
Patient pricing: Most clinics charge the same per-unit rate regardless of which toxin they use. The margin difference goes entirely to the practice.
When Each Makes Sense
| Scenario | Choose Innotox | Choose Botox |
|---|---|---|
| Patient needs results within 48 hours | ✅ | — |
| High-volume clinic (15+ patients/day) | ✅ | — |
| Patient specifically requests Botox by name | — | ✅ |
| US-based clinic needing FDA-approved product | — | ✅ |
| Practitioner wants custom dilution ratios | — | ✅ |
| Maximising wholesale margin | ✅ | — |
Practitioner Summary
Innotox and Botox deliver the same clinical outcome through the same mechanism at the same dose (1:1). The decision is format (liquid vs vacuum-dried), onset speed (24–48h vs 3–5 days), regulatory status (KFDA vs FDA) and economics (wholesale vs brand pricing). Many international clinics stock both — Botox for patients who request it by name, Innotox for operational efficiency and margin optimisation. View Innotox →
Frequently Asked Questions
Is Innotox as strong as Botox?
Yes — 1:1 unit conversion. 20 units of Innotox produces the same muscle relaxation as 20 units of Botox. Same potency, same duration (4–6 months), same peak effect (Day 7–14). The difference is format, not strength.
Does Innotox last as long as Botox?
Yes — both last 4–6 months depending on treatment area and patient metabolism. Onset is faster with Innotox (24–48 hours vs 3–5 days), but the duration of the final effect is equivalent.
Why is Innotox cheaper than Botox?
Korean manufacturing costs are lower than US/European production, and Innotox doesn’t carry Allergan’s brand premium or US marketing costs. The clinical product inside the vial delivers the same result — the price difference reflects manufacturing economics and brand positioning, not quality.
Can I switch patients from Botox to Innotox?
Yes — same units, same injection technique, same anatomical points. No dose recalculation needed. The patient experiences the same clinical outcome with faster onset. Most patients cannot distinguish between the two at peak effect.
Is Innotox FDA approved?
Innotox is KFDA (Korean FDA) approved but does not have US FDA approval. For US-based practices requiring FDA-approved products, Botox or Jeuveau (Nabota) are the options. For international clinics, Innotox is widely used across 60+ countries under KFDA certification.
Related Guides
Disclosure: FillersFairy is a wholesale supplier of Innotox. Botox is a registered trademark of Allergan/AbbVie. This article is for educational purposes only.
References
- Medytox Inc. Innotox product specifications. Liquid BTX-A, 50U/100U, KFDA approved. 2013.
- Allergan Aesthetics. Botox Cosmetic (onabotulinumtoxinA) prescribing information. FDA.
Recommended Products
